Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rougier

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Therapeutic Advances in Medical Oncology|September 2, 2016
Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?Johann Dréanic, Céline Lepère, Mostafa El Hajjam, et al.
Clinics and Research in Hepatology and Gastroenterology|July 7, 2012
An unusual recurrence site for HCC!Edouard Auclin, Cécile Camiliéri, Olivier Dubreuil, et al.
Clinical Colorectal Cancer|October 6, 2010
The timing of chemotherapy and surgery for the treatment of colorectal liver metastasesBernard Nordlinger, Jean-Nicolas Vauthey, Graeme Poston, et al.
Surgery|March 24, 2009
Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastasesAntoine Brouquet, Stéphane Benoist, Catherine Julie, et al.
Cancers|June 8, 2017
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO ReportEric Van Cutsem, Aimery De Gramont, Geoffrey Henning, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2013
Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancerYann Touchefeu, Isabelle Archambeaud, Bruno Landi, et al.
Surgery|August 29, 2006
Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patientsStéphane Benoist, Anne-Sophie Salabert, Christophe Penna, et al.
The American Journal of Cardiology|February 16, 2010
Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart diseaseNicolas Mansencal, William J McKenna, Emmanuel Mitry, et al.
Case Reports in Oncology|June 6, 2012
Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular CarcinomaPauline Gras, Stéphanie Truant, Valérie Boige, et al.
Drugs & Aging|September 28, 2007
Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancerEugeniu Banu, Adela Banu, Andrei Fodor, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Therapeutic Advances in Medical Oncology|September 2, 2016
Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?Johann Dréanic, Céline Lepère, Mostafa El Hajjam, et al.
Clinics and Research in Hepatology and Gastroenterology|July 7, 2012
An unusual recurrence site for HCC!Edouard Auclin, Cécile Camiliéri, Olivier Dubreuil, et al.
Clinical Colorectal Cancer|October 6, 2010
The timing of chemotherapy and surgery for the treatment of colorectal liver metastasesBernard Nordlinger, Jean-Nicolas Vauthey, Graeme Poston, et al.
Surgery|March 24, 2009
Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastasesAntoine Brouquet, Stéphane Benoist, Catherine Julie, et al.
Cancers|June 8, 2017
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO ReportEric Van Cutsem, Aimery De Gramont, Geoffrey Henning, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2013
Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancerYann Touchefeu, Isabelle Archambeaud, Bruno Landi, et al.
Surgery|August 29, 2006
Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patientsStéphane Benoist, Anne-Sophie Salabert, Christophe Penna, et al.
The American Journal of Cardiology|February 16, 2010
Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart diseaseNicolas Mansencal, William J McKenna, Emmanuel Mitry, et al.
Case Reports in Oncology|June 6, 2012
Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular CarcinomaPauline Gras, Stéphanie Truant, Valérie Boige, et al.
Drugs & Aging|September 28, 2007
Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancerEugeniu Banu, Adela Banu, Andrei Fodor, et al.
Pageof 15